Company performance
Add to research
Current Price
as of Apr 21, 2025$4.87
P/E Ratio
N/A
Market Cap
$345.9M
Description
Add to research
Oric Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance. It specializes in hormone-dependent cancers, key tumor dependencies, and precision oncology. The company was founded by Charles L. Sawyers, Richard A. Heyman, and Scott Lowe in 2014 and is headquartered in South San Francisco, CA.
Metrics
Add to research
Overview
- HQSouth San Francisco, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerORIC
- Price$4.87+2.10%
Trading Information
- Market cap$345.90M
- Float60.52%
- Average Daily Volume (1m)892,304
- Average Daily Volume (3m)1,082,643
- EPS-$1.83
Company
- RevenueN/A
- Rev growth (1yr)N/A
- Net income-$127.85M
- Gross marginN/A
- EBITDA marginN/A
- EBITDA-$141.79M
- EV$316.10M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
- P/B1.42
- Debt/Equity3.85
Documents
Add to research
SEC Filings
Factset Street Account